Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry.

Details

Ressource 1Download: S221103.pdf (2532.73 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_2C227A49D052
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry.
Journal
Multiple sclerosis and related disorders
Author(s)
Stanikić M., Salmen A., Chan A., Kuhle J., Kaufmann M., Ammann S., Schafroth S., Rodgers S., Haag C., Pot C., Kamm C.P., Zecca C., Gobbi C., Calabrese P., Manjaly Z.M., von Wyl V.
Working group(s)
Swiss Multiple Sclerosis Registry (SMSR)
ISSN
2211-0356 (Electronic)
ISSN-L
2211-0348
Publication state
Published
Issued date
11/2022
Peer-reviewed
Oui
Volume
67
Pages
104084
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
While comorbidities increase with age, duration of multiple sclerosis (MS) leads to disability accumulation in persons with MS. The influence of ageing vis-a-vis MS duration remains largely unexplored. We studied the independent associations of ageing and MS duration with disability and comorbidities in the Swiss MS Registry participants.
Self-reported data was cross-sectionally analyzed using confounder-adjusted logistic regression models for 6 outcomes: cancer, type 2 diabetes (T2D), hypertension, cardiac diseases, depression, and having at least moderate or severe gait disability. Using cubic splines, we explored non-linear changes in risk shapes.
Among 1615 participants age was associated with cardiac diseases (OR 1.05, 95% CI [1.02, 2.08]), hypertension (OR 1.08, 95% CI [1.06, 2.10]), T2D (OR 1.10, 95%CI [1.05, 1.16]) and cancer (OR 1.04, 95% CI [1.01, 1.07]). MS duration was not associated with comorbidities, except for cardiac diseases (OR 1.03, 95% CI [1.00, 1.06]). MS duration and age were independently associated with having at least moderate gait disability (OR 1.06, 95% CI [1.04, 1.07]; OR 1.04, 95% CI [1.02, 1.05], respectively), and MS duration was associated with severe gait disability (OR 1.05, 95% CI [1.03, 1.08]). The spline analysis suggested a non-linear increase of having at least moderate gait disability with age.
Presence of comorbidities was largely associated with age only. Having at least moderate gait disability was associated with both age and MS duration, while having severe gait disabity was associated with MS duration only.
Keywords
Humans, Multiple Sclerosis/epidemiology, Diabetes Mellitus, Type 2, Switzerland/epidemiology, Registries, Hypertension, Heart Diseases/epidemiology, Ageing, Comorbidity, Disability, Disease duration, Multiple sclerosis
Pubmed
Web of science
Open Access
Yes
Create date
24/08/2022 9:59
Last modification date
16/04/2024 7:15
Usage data